Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy

Safety, Efficacy and Operability of Using the New Tissue Containment System With Hard Pipes Which Can Assemble With Detachable Trocars Seamlessly for Tissue Removal During Laprascopic Hysterectomy

The study is designed to evaluate the safety, operability and efficacy of performing the new tissue containment system during laparoscopic hysterectomy. Pre- and perimenopausal women undergoing laparoscopic hysterectomy.

Inclusion Criteria:

• Pre- and Peri-menopausal woman patient age 18-65 years
• Women with fibroids, adenomyosis, and endometrial hyperplasia and indication for laparoscopic hysterectomy.
• Normal Pap smear result within one year
• The uterus is larger than 12 weeks of gestation
• The body mass index of the patients is 18.5-27.9kg/m2
• Signed informed consent form

Exclusion Criteria:

• Women with Known or suspected malignancy
• patients during pregnancy and lactation
• Known blood diseases, bleeding coagulation disease, any part of the active bleeding or bleeding tendency of the constitution of the patient
• Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST) ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit
• Patients who are known to have participated in any other clinical trial within 3 months
• Patients who cannot sign informed consent
• Patients with acute stage infection of the reproductive system or other sites